Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00002438
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
A Study of Itraconazole in the Prevention of Histoplasmosis a Fungal Infection in HIV-Infected Patients
Sponsor:
Janssen LP
Organization:
NIH AIDS Clinical Trials Information Service
Study Overview
Official Title:
Randomized Study Comparing Itraconazole to Placebo in the Prevention of Histoplasmosis in Patients With Human Immunodeficiency Virus Infection
Status:
COMPLETED
Status Verified Date:
1996-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To assess the safety and efficacy of itraconazole versus placebo for prevention of histoplasmosis in HIV-infected patients with CD4 counts 150 cellsmm3 who reside where histoplasmosis is endemic To assess the safety and efficacy of itraconazole for preventing other debilitating fungal infections such as cryptococcosis aspergillosis recalcitrant oropharyngeal or vaginal candidiasis and recurrent esophageal candidiasis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| ITR-USA-73 | None | None | None |
| MSG 28 | None | None | None |